Bax is an oncogene that has proapoptotic properties but not all cells that express Bax undergo apoptosis. Bax may have a function unrelated to apoptosis. To elucidate the role of Bax in cell signaling, an epithelial cell line called SMG-C6 was transfected with the human bax gene. Stable transfectants were studied for their response to carbachol, a muscarinic receptor agonist, by measuring the increase in intracellular free Ca 2+ and Ca
Bax is an oncogene that has proapoptotic properties but not all cells that express Bax undergo apoptosis. Bax may have a function unrelated to apoptosis. To elucidate the role of Bax in cell signaling, an epithelial cell line called SMG-C6 was transfected with the human bax gene. Stable transfectants were studied for their response to carbachol, a muscarinic receptor agonist, by measuring the increase in intracellular free Ca 2+ and Ca 2+ in¯ux. Carbachol-mediated release of Ca 2+ from intracellular stores was signi®cantly higher in Bax transfectants compared to control transfectants (empty vector). Ca 2+ in¯ux was also increased in Bax transfectants. Bax had no aect on the storage operated channels. However, the concentration of Ca 2+ in the intracellular stores (i.e., mitochondria and granules) was 40 ± 50% lower in the Bax transfectants. There was no signi®cant dierence in thapsigargin-mediated apoptosis in Bax transfectants compared to wild-type and control transfectants. Measurement of glutathione was reduced in the Bax transfectant. Restoration of glutathione levels with glutathione monoethyl ester partially normalized Ca 2+ mobilization and storage capacity in the mitochondria to control levels. This study shows that subapoptotic levels of Bax can reduce Ca 2+ content in intracellular stores and Ca 2+ homeostasis. Bax may mediate these eects by reducing the levels of antioxidants resulting in mild oxidative stress. Oncogene (2002) 21, 2762 ± 2767. DOI: 10.1038/sj/ onc/1205369
Keywords: calcium; Bcl-2 family; oxidative stress; glutathione; muscarinic receptor Bax is a member of the Bcl-2 oncogene family that regulates apoptosis (Gross et al., 1999) . Members such as Bcl-2 and Bcl-x L have cytoprotective properties, whereas Bak, Bax and Bid are proapoptotic. In many cells undergoing apoptosis, Bax interacts with Bid and undergoes a conformational change (Desagher et al., 1999) . This causes Bax to translocate from the cytoplasm to the mitochondria mediating an eux of cytochrome c. However, many tissues express high levels of Bax without showing classical apoptotic features (Krajewski et al., 1994; Olive and Ferrer, 1999; Penault-Llorca et al., 1998) . This suggests that Bax may participate in other cell functions other than apoptosis. For example, the enforced expression of Bax can retard cell cycle progression (Brady et al., 1996) . Ca 2+ plays an important role in apoptosis (McConkey and Orrenius, 1996) and, therefore, it is not surprising that the Bcl-2 family aects Ca 2+ homeostasis (Foyouzi-Yousse® et al., 2000; Kuo et al., 1998; Murphy et al., 1996; Wei et al., 1998) . In NRK rat kidney cells, enforced expression of Bcl-2 causes a slow release of intracellular free Ca 2+ ([Ca 2+ ] i ) after oxidative stress (Ichimiya et al., 1998) . Moreover, overexpression of Bcl-2 enhanced the mitochondrial Ca 2+ uptake by 1.7-fold in permeabilized GT1-7 neuronal cells and 3.9-fold in isolated GT1-7 mitochondria (Murphy et al., 1996) . Similar ®ndings have been observed with Bcl-x L (Zhou et al., 2000) . This suggests that the Bcl-2 family regulate Ca 2+ signaling. It has been shown that Bak and Bax can regulate apoptosis by altering Ca 2+ homeostasis (Nutt et al., 2002) . However, to date, there are no studies reporting the role of Bax in Ca 2+ signaling. To address the role of Bax in Ca 2+ signaling, the epithelial rat cell line, SMG-C6 was transfected with the human Baxa gene and clones were established. Stable transfectants showed increased levels of Bax compared to wild-type cells and control transfectants. The intensity of Bax staining is similar to that observed in salivary tissue (Kong et al., 1998; Masago et al., 2001; Polihronis et al., 1998) . There were no gross abnormal changes in morphology and these transfectants did not undergo spontaneous apoptosis in culture ( Figure 1a ).
Studies were performed to localize Bax by confocal microscopy. Upon an apoptotic signal, Bax translo- Figure 1 Expression of Bax in a cloned transfected SMG-C6 cell line. A rat submandibular acinar cell line called SMG-C6 (Quissell et al., 1997) was transfected with the pSFFV.neo expression vector (Boise et al., 1993) . The human bax-a cDNA was kindly provided by Dr B DoÈ rken (Berlin-Buch, Germany) (Bargou et al., 1996) . The bax-a cDNA was excised from its host plasmid, pUHD 10-3, by XbaI restriction enzyme digestion (New England Biolabs, Beverly, MA, USA). An EcoRI ± NotI adaptor was buntend ligated to the bax-a fragment and subjected to EcoRI digestion. The restriction fragment was religated into the EcoRI site of pSFFV.neo. Cells were transfected with LipofecTAMINE TM (GIBCO ± BRL Life Technologies, Inc., Gaithersburg, MD, USA) according to the manufacturer's instructions. Stable transfectants were selected with Geneticin (500 mg/ml), (GIBCO ± BRL Life Technologies) and cloned by limiting dilution. Cells and the Bax transfectant were grown on glass slides, ®xed with paraformaldehyde, and stained, for Bax using a rabbit antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). A peroxidase (a; 4006) or¯uorescent (b, 8006) immunoconjugate was used as a second antibody. Confocal microscopy was used to co-localize Bax and mitochondria. Mitochondria were stained with MitoTracker Red (Molecular Probes, Eugene, OR, USA). To induce apoptosis in transfected cells, recombinant soluble Fas ligand (0.1 mg/ml) and an antibody potentiator (6 mg/ml) (Upstate Biotechnology, Inc., Lake Placid, NY, USA), or thapsigargin (3 mM) was added to cultures for 17 or 36 h, respectively. Cultures were assessed for mitochondrial membrane potential or nuclear DNA content by staining cells with tetramethyl rhodaminemethyl ester (c) (Metivier et al., 1998) or propidium iodide (Nicoletti et al., 1991) (d), respectively. Thapsigargin-induced apoptosis was assessed in a cloned Bax and control transfectant in a dose-dependent manner (e) ] i and Ca 2+ in¯ux was determined using the Ca 2+ sensitive¯uorescent indicator fura-2 (Molecular Probes) as previously described (Zhang et al., 1997) . Brie¯y, cells were loaded with fura-2 (2 mM) for 20 min at 378C. Fura-2¯uorescence was continuously monitored with a PTI Deltascan¯uorometer (PTI Inc., S. Brunswick, NJ, USA). The excitation wavelengths used were 340 and 380 nm and the emission wavelength was 505 nm. Fluorescence ratios of the 340/380 nm excitation and 505 nm emission were converted to [Ca 2+ ] i according to Grynkiewicz et al. (1985) using 224 nM as the K d of fura-2 for Ca 2+ at 378C. Ca 2+ release from intracellular stores was mediated by the addition of carbachol (10 mM), a muscarinic receptor agonist under Ca ] i changes was used to calculate Ca 2+ in¯ux rate (nM/min). To measure [Ca 2+ ] in the endoplasmic reticulum, mitochondria, and secretory granules fura-2-loaded cells were sequentially treated with thapsigargin (3 mM), ionomycin (1 mM) and monensin (10 mM) (e and f). A representative¯uorescence pro®le is shown in panel e. Bars represent the mean+s.d. Statistical analysis was tested by a one-way analysis of variance (ANOVA). P50.05 was considered as statistically signi®cant versus wild-type and control values cates to the mitochondria. Using confocal microscopy, Bax was located predominantly in the cytoplasm (Figure 1b) . Further, con®rmation that Bax is not located in the mitochondria is the measurement of mitochondrial membrane potential. Tetramethylrhodamine ester staining showed no statistically signi®cant dierence between wild-type and the Bax transfectant. Furthermore, there was no statistically signi®cant dierence in mitochondrial membrane potential after inducing apoptosis with soluble CD95 ligand ( Figure  1c) .
Increased Bax expression in SMG-C6 cells did not aect sensitivity to an apoptotic signal. Apoptosis was induced by thapsigargin, an inhibitor of Ca 2+ dependent ATPase. After 36 h, apoptosis was observed in 27% of wild-type cells and control transfectants (Figure 1d ). Similar percentage (30%) of apoptosis was observed in the Bax transfectant. Likewise, there was no dierence between the control and Bax transfectant in CD95-mediated apoptosis (data not shown). Finally, Bax did not cause the cells to be more sensitive to thapsigargin-induced apoptosis, since the dose response curve was the same between the control and Bax transfectant (Figure 1e ). This shows that the level of Bax in SMG-C6 cells was not sucient to aect the apoptotic pathway.
Sub (Figure 2a,c, respectively) . The increase in [Ca 2+ ] i was observed in several clone Bax transfectants (Figure 2b ). This increase in [Ca 2+ ] i and Ca 2+ in¯ux was not due to an increase in the number of cells responding to carbachol. Flow cytometry of fura-2-loaded cells showed no signi®cant dierence in the number of cells responding to carbachol (83 ± 92%) between control and Bax transfectants (data not shown). To show that Bax aected Ca 2+ in¯ux through the storage operated channels, Ca 2+ in¯ux was measured after treatment with thapsigarin ( Figure  2c ). Bax had no aect on the storage operated channels.
Bcl-2 can decrease cellular Ca 2+ stores. Therefore, Bax may enhance the apoptotic potential of cells by increasing the cell's Ca 2+ content. The Bax transfectant was sequentially treated with thapsigargin, ionomycin, and monesin to measure Ca 2+ concentrations in the endoplasmic reticulum, mitochondria and secretory granules, respectively (Figure 2d) . Surprisingly, subapoptotic levels of Bax signi®cantly decreased Ca 2+ concentrations in the mitochondria and secretory granules but not in the endoplasmic reticulum. These results are in contrast to the work of Nutt et al. (2002) who showed that apoptotic levels of Bax deplete Ca 2+ in the endoplasmic reticulum while elevating mitochondrial Ca 2+ stores.
Apoptosis induces oxidative stress in many cells (Buttke and Sandstrom, 1995) . Indeed, one of the early characteristics of apoptosis is the depletion of glutathione (Ghibelli et al., 1995 (Ghibelli et al., , 1999 . In brain, Bax expression lowers resistance threshold to oxidative stress (Azhar et al., 1999) . Moreover, FL5.12 cells, a prolymphocytic cell line, transfected with Bax showed *30% reduction in glutathione levels (Bojes et al., 1997) . Bax may aect Ca 2+ mobilization and storage in SMG-C6 cells by lowering the cell's antioxidant levels. Reduced glutathione levels were measured in SMG-C6 transfectants (Figure 3) . The basal levels of reduced glutathione in the Bax transfectant was 15 ± 20% lower compared to the control transfectant. This level of glutathione depletion (*20%) is similar to the level of depletion in a neurosecretory cell line, PC12, causing a dysregulation in calcium signaling (Wang and Joseph, 2000) . Lowering median glutathione levels by as little as 10% signi®-cantly decreased receptor-mediated Ca 2+ in¯ux in lymphocytes (Staal et al., 1994) . Furthermore, carbachol depleted glutathione levels in the both transfected SMG-C6 cells. But the percentage of glutathione depletion was less in the Bax transfectant compared to the control transfectant (data not shown). The basal level of reduced glutathione in the Bax transfectant was greater than that observed in cells undergoing apoptosis (e.g., 495% depletion). This is consistent with the notion that Bax is being expressed at a sub-apoptotic level.
To show a relationship between reduced glutathione levels and altered Ca 2+ mobilization in the Bax transfectant, cells were treated with glutathione mono- Figure 3 Bax reduces glutathione levels in SMG-C6 cells. Transfected cells were incubated with or without recombinant soluble Fas ligand (0.1 mg/ml) and an antibody potentiator (6 mg/ml) (Upstate Biotechnology) for 24 h, cell lysates were derived from 5610 6 transfectants to measure glutathione. ApoAlert TM Glutathione Detection Kit (Clontech, Palo Alto, CA, USA) was used to measure cytostolic reduced glutathione in cell lysates. Mono-chlorobimane was added to cell lysates. (Kuo et al., 1998; Murphy et al., 1996; Pinton et al., 2000) .
High expression of Bax has been observed in nonapoptotic normal tissues (Krajewski et al., 1994; Penault-Llorca et al., 1998) . It is thought that Bax may participate in maintaining cell homeostasis in these tissues. For example, Bax: (1) can induce cell cycle arrest at G1 by inducing the expression of p21 kip1 (Brady et al., 1996) ; and (2) may alter Ca 2+ mobilization by modulating molecules that regulate Ca 2+ transport. It is interesting to note that Bcl-2 increases expression of the endoplasmic reticulum calcium pump (SERCA) in epithelial cells (Kuo et al., 1998) . Increased expression of SERCA accelerated calcium uptake and enhanced Ca 2+ loading in these cells. Bax may mediate its action by altering the cell's redox potential. Perhaps, Bax may act by lowering glutathione levels. In neuroblastoma cells, carbachol leads to the production of reactive oxygen species and elevated [Ca 2+ ] i (Naarala et al., 1997) . This study shows a relationship between carbachol stimulation and possible regulation by antioxidants. In the SMG-C6 Bax transfectant, nontoxic levels of reactive oxygen species may be generated resulting in enhanced Ca 2+ mobilization. Receptor signaling in a T cell leukemia Figure 4 Glutathione monoethyl ester (GSHE) restores normal Ca 2+ mobilization and storage capacity. GSHE (®nal concentration=50 mM) was added to cultures 24 h and 30 min prior to cell harvest. Transfectants were assessed for Ca 2+ mobilization and in¯ux (a, b and c), and storage (d) as described in Figure 2 . A representative¯uorescence pro®le is shown in a. Statistical analysis was tested by a one-way analysis of variance (ANOVA). P50.05 was considered as statistically signi®cant versus their corresponding`Control' values without GSHE cell line is enhanced when intracellular thiol pools are partially depleted (Hehner et al., 2000) . In yeast cells transfected with Bax, intracellular levels of total glutathione and mitochondrial membrane potential are decreased. However, when a plant glutathione peroxidase is co-expressed with Bax, glutathione levels and mitochondrial membrane potential were restored to normal values (Kampranis et al., 2000) . These studies point to a possible mechanism by which Bax regulates normal nonapoptotic cell function by altering the cell's anti-oxidation defense system.
The nonapoptotic function of Bax may have clinical relevance. In SjoÈ gren's syndrome (i.e., autoimmune exocrinopathy), the salivary epithelial cells express abnormal levels of Bax (Kong et al., 1998; Polihronis et al., 1998) . Interestingly, elevated Bax expression was present in both apoptotic and nonapoptotic cells (Masago et al., 2001) . Bax expression in the salivary gland may explain the extent of salivary abnormalities that cannot be fully accounted by apoptosis alone (Ohlsson et al., 2001) .
